OSE Pharma Price To Earning vs. EBITDA
| OSE Stock | EUR 7.27 0.21 2.97% |
For OSE Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of OSE Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well OSE Pharma SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between OSE Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of OSE Pharma SA over time as well as its relative position and ranking within its peers.
OSE |
OSE Pharma SA EBITDA vs. Price To Earning Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining OSE Pharma's current stock value. Our valuation model uses many indicators to compare OSE Pharma value to that of its competitors to determine the firm's financial worth. OSE Pharma SA is regarded fifth in price to earning category among its peers. It is considered to be number one stock in ebitda category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value OSE Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OSE Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.OSE EBITDA vs. Price To Earning
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
OSE Pharma |
| = | 10.60 X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
OSE Pharma |
| = | (13.72 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
OSE EBITDA Comparison
OSE Pharma is currently under evaluation in ebitda category among its peers.
OSE Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in OSE Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, OSE Pharma will eventually generate negative long term returns. The profitability progress is the general direction of OSE Pharma's change in net profit over the period of time. It can combine multiple indicators of OSE Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
OSE Immunotherapeutics SA, a biotechnology company, focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. OSE Immunotherapeutics SA is headquartered in Nantes, France. OSE IMMUNO operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 34 people.
OSE Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on OSE Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of OSE Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the OSE Pharma's important profitability drivers and their relationship over time.
Use OSE Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OSE Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OSE Pharma will appreciate offsetting losses from the drop in the long position's value.OSE Pharma Pair Trading
OSE Pharma SA Pair Trading Analysis
The ability to find closely correlated positions to OSE Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OSE Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OSE Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OSE Pharma SA to buy it.
The correlation of OSE Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OSE Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OSE Pharma SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OSE Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your OSE Pharma position
In addition to having OSE Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Obamacare Thematic Idea Now
Obamacare
Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program. The Obamacare theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in OSE Stock
To fully project OSE Pharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of OSE Pharma SA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include OSE Pharma's income statement, its balance sheet, and the statement of cash flows.